An experimental antibiotic called EVG7 has shown promise against gram-positive bacterium Clostridioides difficile. | Drug Discovery And Development ...
Vancomycin 265/309 (85.8%) 76/265 (25.3%) 198/309 (64.1%) †Clinical cure is resolution of diarrhea following the recommended dose of drug (fidaxomicin: 200 mg twice a day; vancomycin: 125 mg four ...
Expert Rev Anti Infect Ther. 2011;9(6):657-667. The relationship between MRSA vancomycin MIC and mortality in vancomycin-treated patients with hospital acquired pneumonia, ventilator-associated ...
A newly developed antibiotic called EVG7 could offer a powerful new way to stop Clostridioides difficile, a dangerous gut bacterium that often returns after treatment. In mouse studies, researchers ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found. Results published in the Journal of Crohn's and Colitis ...
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from ...
The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results